<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Saldaris J</submitter><funding>NINDS NIH HHS</funding><funding>NIH</funding><funding>International Foundation for CDKL5 Research</funding><pagination>541-547</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9149062</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>37(6)</volume><pubmed_abstract>Pathogenic variants in the &lt;i>CDKL5&lt;/i> gene result in CDKL5 deficiency disorder (CDD), which is characterized by early-onset epilepsy, severe developmental delay, and often, cortical visual impairment. Validated clinical outcome measures are needed for future clinical trials to be successful. This study aimed to adapt the Rett Syndrome Hand Function Scale for CDKL5 deficiency disorder and evaluate its feasibility, acceptability, content validity, and reliability. Consultation with a cortical visual impairment experienced specialist and the Consumer Reference Group informed modifications to the instructions of the Rett Syndrome Hand Function Scale for children with CDKL5 deficiency disorder (CDD-Hand). Eighty-six families registered with the International CDKL5 Disorder Database provided v</pubmed_abstract><journal>Journal of child neurology</journal><pubmed_title>Initial Validation and Reliability of the CDKL5 Deficiency Disorder Hand Function Scale (CDD-Hand).</pubmed_title><pmcid>PMC9149062</pmcid><funding_grant_id>U01 NS114312</funding_grant_id><funding_grant_id>1U01NS114312-01A1</funding_grant_id><pubmed_authors>Demarest S</pubmed_authors><pubmed_authors>Saldaris J</pubmed_authors><pubmed_authors>Benke TA</pubmed_authors><pubmed_authors>Jacoby P</pubmed_authors><pubmed_authors>Downs J</pubmed_authors><pubmed_authors>Leonard H</pubmed_authors><pubmed_authors>Marsh ED</pubmed_authors></additional><is_claimable>false</is_claimable><name>Initial Validation and Reliability of the CDKL5 Deficiency Disorder Hand Function Scale (CDD-Hand).</name><description>Pathogenic variants in the &lt;i>CDKL5&lt;/i> gene result in CDKL5 deficiency disorder (CDD), which is characterized by early-onset epilepsy, severe developmental delay, and often, cortical visual impairment. Validated clinical outcome measures are needed for future clinical trials to be successful. This study aimed to adapt the Rett Syndrome Hand Function Scale for CDKL5 deficiency disorder and evaluate its feasibility, acceptability, content validity, and reliability. Consultation with a cortical visual impairment experienced specialist and the Consumer Reference Group informed modifications to the instructions of the Rett Syndrome Hand Function Scale for children with CDKL5 deficiency disorder (CDD-Hand). Eighty-six families registered with the International CDKL5 Disorder Database provided v</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 May</publication><modification>2025-04-22T11:48:59.94Z</modification><creation>2025-04-06T00:07:40.64Z</creation></dates><accession>S-EPMC9149062</accession><cross_references><pubmed>35422141</pubmed><doi>10.1177/08830738221091044</doi></cross_references></HashMap>